Second-generation antipsychotics and pregnancy complications: the impact of confounding by indication

Eur J Clin Pharmacol. 2021 Mar;77(3):439-440. doi: 10.1007/s00228-020-03025-5. Epub 2020 Oct 20.

Authors

Olorunfemi A Oshagbemi¹, Abraham Daniel², Ismaeel Yunusa³

Affiliations

¹ Quantitative Safety and Epidemiology, Novartis Pharma AG, Basel, Switzerland.
² Division of Pharmacy, University of Tasmania, Hobart, Tasmania, Australia.
³ College of Pharmacy, University of South Carolina, Columbia, SC, USA. iyunusa@mailbox.sc.edu.

PMID: 33079218
DOI: 10.1007/s00228-020-03025-5

No abstract available

Publication types

Letter
Comment

MeSH terms

Antipsychotic Agents*
Family Characteristics
Female
Humans
Pregnancy

Substances

Antipsychotic Agents